Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/08/25
End: 08/08/28
Due: 08/08/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary | NCT06869174 | Zhiguo Luo, MD, PhD | user2@example.com | None | 2025-03-08 | 2028-08-08 | 2029-08-08 | - | - | 2025-07-14 |